IT1227154B - Composizioni farmaceutiche per uso ginecologico a base di lattobacilli - Google Patents

Composizioni farmaceutiche per uso ginecologico a base di lattobacilli

Info

Publication number
IT1227154B
IT1227154B IT8821663A IT2166388A IT1227154B IT 1227154 B IT1227154 B IT 1227154B IT 8821663 A IT8821663 A IT 8821663A IT 2166388 A IT2166388 A IT 2166388A IT 1227154 B IT1227154 B IT 1227154B
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
lattobacilli
use based
gynecological use
gynecological
Prior art date
Application number
IT8821663A
Other languages
English (en)
Other versions
IT8821663A0 (it
Inventor
Silvana Tosi
Giancarla Dondi
Vittorio Bottazzi
Franco Dellaglio
Lorenzo Morelli
Original Assignee
A Tosi Farmaceutici S R L Nova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Tosi Farmaceutici S R L Nova filed Critical A Tosi Farmaceutici S R L Nova
Priority to IT8821663A priority Critical patent/IT1227154B/it
Publication of IT8821663A0 publication Critical patent/IT8821663A0/it
Priority to EP89113574A priority patent/EP0353581B1/en
Priority to AT89113574T priority patent/ATE113650T1/de
Priority to DE68919146T priority patent/DE68919146D1/de
Priority to US07/388,479 priority patent/US5176911A/en
Priority to JP1201145A priority patent/JPH02174675A/ja
Priority to ZA895936A priority patent/ZA895936B/xx
Application granted granted Critical
Publication of IT1227154B publication Critical patent/IT1227154B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
IT8821663A 1988-08-05 1988-08-05 Composizioni farmaceutiche per uso ginecologico a base di lattobacilli IT1227154B (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT8821663A IT1227154B (it) 1988-08-05 1988-08-05 Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
EP89113574A EP0353581B1 (en) 1988-08-05 1989-07-24 Pharmaceutical compositions comprising selected lactobacillus strains
AT89113574T ATE113650T1 (de) 1988-08-05 1989-07-24 Ausgewählte stämme von lactobacillus enthaltende pharmazeutische zusammensetzungen.
DE68919146T DE68919146D1 (de) 1988-08-05 1989-07-24 Ausgewählte Stämme von Lactobacillus enthaltende pharmazeutische Zusammensetzungen.
US07/388,479 US5176911A (en) 1988-08-05 1989-08-02 Pharmaceutical compositions comprising selected lactobacillus strains
JP1201145A JPH02174675A (ja) 1988-08-05 1989-08-02 特定のラクトバチラス菌よりなる製薬組成物
ZA895936A ZA895936B (en) 1988-08-05 1989-08-03 Pharmaceutical compositions comprising selected lactobacillus strains

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8821663A IT1227154B (it) 1988-08-05 1988-08-05 Composizioni farmaceutiche per uso ginecologico a base di lattobacilli

Publications (2)

Publication Number Publication Date
IT8821663A0 IT8821663A0 (it) 1988-08-05
IT1227154B true IT1227154B (it) 1991-03-19

Family

ID=11185025

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8821663A IT1227154B (it) 1988-08-05 1988-08-05 Composizioni farmaceutiche per uso ginecologico a base di lattobacilli

Country Status (7)

Country Link
US (1) US5176911A (it)
EP (1) EP0353581B1 (it)
JP (1) JPH02174675A (it)
AT (1) ATE113650T1 (it)
DE (1) DE68919146D1 (it)
IT (1) IT1227154B (it)
ZA (1) ZA895936B (it)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672494A1 (fr) * 1991-02-13 1992-08-14 Madinier Isabelle Ferments prophylactiques favorisant la prevention de la carie dentaire.
GB2261372A (en) * 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection
FI92498C (fi) * 1992-06-10 1994-11-25 Valio Meijerien Uusi mikro-organismikanta, sitä sisältävät bakteerivalmisteet ja näiden käyttö hiivojen ja homeiden torjuntaan
US5269959A (en) * 1992-09-16 1993-12-14 Gary Schreibman Liquid deep cleaning detergent composition
ZA942302B (en) * 1993-12-03 1995-09-29 Lafor Lab Ltd Viracidal bactericidal and spermicidal vaginal suppository
JPH11504048A (ja) * 1996-02-14 1999-04-06 ザ、プロクター、エンド、ギャンブル、カンパニー 泌尿生殖器および腸用の組成物
AUPN907296A0 (en) * 1996-04-02 1996-04-26 Commonwealth Scientific And Industrial Research Organisation Biocontrol agents for use in treatment of opportunistic infections
US6093394A (en) 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
EP0872231B1 (en) * 1997-04-14 2002-09-04 Dr. A. Tosi Farmaceutici S.R.L. Pharmaceutical compositions comprising lactobacilli suitable for trans-mucosal administration
JP4678896B2 (ja) * 1997-04-18 2011-04-27 ガネデン バイオテック，インコーポレイテッド 微生物感染を予防または制御するための共生Ｂａｃｉｌｌｕｓ芽胞の局所的使用
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US6716435B1 (en) * 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
US7507402B1 (en) 1997-04-18 2009-03-24 Ganeden Biotech, Inc. Topical use of probiotic Bacillus spores to prevent or control microbial infections
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
IT1299070B1 (it) * 1998-04-10 2000-02-07 Proge Farm Srl Ceppi di lattobacilli capaci di inibire e/o avere azione microbicida nei confronti di microorganismi patogeni e metodo di induzione e
SE519648C2 (sv) 1998-03-06 2003-03-25 Essum Ab Ny stam av Lactobacillus plantarum
US6811786B1 (en) * 1999-04-01 2004-11-02 Ganeden Biotech, Inc. Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions
DE69802260T2 (de) * 1998-04-30 2002-07-04 Vesely Renata Maria Cavaliere Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
US7767203B2 (en) * 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
EP1719518A1 (en) 1998-08-07 2006-11-08 Ganeden Biotech, Inc. Compositions comprising bacillus coagulans for increasing the solubility and bioavailability of nutritional minerals
US6461607B1 (en) 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
WO2001013956A2 (en) * 1999-08-26 2001-03-01 Ganeden Biotech, Inc. Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications
US6849256B1 (en) * 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
US6767537B2 (en) * 2000-05-26 2004-07-27 Phil Arnold Nicolay Composition and method for the treatment of sinusitis
CN1444484A (zh) * 2000-06-19 2003-09-24 穆科普罗泰科有限公司 用益生菌对粘膜表面的细菌或病毒感染进行治疗或免疫治疗及用于此的组合物
KR20030065463A (ko) 2000-08-11 2003-08-06 데이비드 알. 휘트록 질소 산화물 및 질소 산화물 전구체의 생산을 증가시키기위한 암모니아 산화 박테리아를 포함하는 조성물 및 이를이용하는 방법
SE521022C2 (sv) * 2001-09-20 2003-09-23 Ellen Ab Mjölksyraproducerande bakterier för användning som probiotiska organismer i vaginan hos människa
EE04580B1 (et) * 2001-06-29 2006-02-15 Tartu �likool Mikroorganismi tüvi Lactobacillus fermentum ME-3 kui antimikroobne ja antioksüdantne probiootikum
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition
EP1472021A4 (en) * 2002-01-11 2008-04-16 David R Whitlock AMMONIAX OXIDIZING BACTERIA CONTAINING COMPOSITIONS AND USER METHOD THEREFOR
US20040071679A1 (en) * 2002-10-15 2004-04-15 Claudio De Simone Identifying and treating vaginal infections
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
WO2006045347A1 (en) 2004-10-22 2006-05-04 Medinova Ag Lactobacillus helveticus strain useful in the treatment or prevention of infections caused by urogenital pathogens
AU2006253006B8 (en) 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
BRPI0611492B1 (pt) 2005-05-31 2021-10-13 Mars, Incorporated Bifidobactéria probiótica felina
KR100720025B1 (ko) 2005-09-27 2007-05-21 (주)바이오토피아 프로바이오틱 유산균 및 이를 포함하는 조성물
US20070286813A1 (en) * 2006-06-09 2007-12-13 Toutounghi Camille Nasal formulation
KR100720024B1 (ko) 2006-12-20 2007-05-18 (주)바이오토피아 프로바이오틱 비피도박테리움 보움 ｒ5 균주 및 이를포함하는 조성물
MX2009008166A (es) 2007-02-01 2009-08-12 Iams Company Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate.
LT2211626T (lt) 2007-08-29 2019-11-11 Ganeden Biotech Inc Kepiniai
ES2700855T3 (es) * 2007-10-16 2019-02-19 Ganeden Biotech Inc Composiciones bebibles
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2158916A1 (en) * 2008-08-27 2010-03-03 Ellen Aktiebolag Administration unit comprising lactic acid bacteria
US9622502B2 (en) 2008-10-16 2017-04-18 Ganeden Biotech, Inc. Probiotic Bacillus pasta compositions
US20100260695A1 (en) * 2009-04-09 2010-10-14 Mary Kay Inc. Combination of plant extracts to improve skin tone
ES2639364T3 (es) 2009-04-29 2017-10-26 Ganeden Biotech, Inc. Formulación de membrana celular bacteriana
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
JP4942831B2 (ja) 2010-03-19 2012-05-30 株式会社キティー 抗アレルギー用組成物
EE05750B1 (et) 2011-02-25 2015-06-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine
WO2012135499A1 (en) 2011-03-31 2012-10-04 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
EP2709456A1 (en) 2011-05-20 2014-03-26 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Paenibacillus alvei strain ts-15 and its use in controlling pathogenic organisms
RU2014141201A (ru) 2012-03-29 2016-05-20 ТЕРАБАЙОМ, ЭлЭлСи Композиции для желудочно-кишечной сайт-специфической пероральной вакцинации, проявляющие активность в подвздошной кишке и аппендиксе
EP2656862A1 (en) 2012-04-24 2013-10-30 The Procter & Gamble Company Substrate comprising one or more human milk oligosaccharides and disposable absorbent article comprising the substrate
WO2014106541A1 (en) * 2013-01-04 2014-07-10 Ellen Ab Dermal composition for use in the external genital area in females
JP6464142B2 (ja) 2013-03-14 2019-02-06 セラバイオーム，エルエルシー プロバイオティクス生物及び／又は治療剤の標的化胃腸管デリバリー
US11225640B2 (en) 2014-04-15 2022-01-18 Aobiome Llc Ammonia oxidizing bacteria for treatment of psoriasis
CN106456678A (zh) 2014-04-15 2017-02-22 Ao生物医学有限责任公司 氨氧化型亚硝化单胞菌菌株d23
US11166968B2 (en) 2015-09-29 2021-11-09 Kimberly-Clark Worldwide, Inc. Synergistic composition for maintenance of healthy balance of microflora
PL241510B1 (pl) 2015-11-06 2022-10-17 Probios Spolka Z Ograniczona Odpowiedzialnoscia Nowy szczep Lactobacillus plantarum AMT14 i kompozycja zawierająca szczep Lactobacillus plantarum AMT14
US10166262B2 (en) 2017-04-20 2019-01-01 Ewelina Sosnowska-Turek Strain of bacteria and composition comprising the same
US20210401806A1 (en) * 2020-06-30 2021-12-30 Vireo Systems, Inc. Compositions and methods for treatment of vaginal infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6836M (it) * 1967-11-29 1969-03-31
DK127268A (it) * 1970-01-12 1900-01-01
FI59925C (fi) * 1980-01-11 1981-11-10 Esko Viljo Nurmi Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
DK242083D0 (da) * 1983-05-27 1983-05-27 Hansens Chr Bio Syst Vaginalkapsler
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection

Also Published As

Publication number Publication date
EP0353581A2 (en) 1990-02-07
EP0353581B1 (en) 1994-11-02
ZA895936B (en) 1990-05-30
DE68919146D1 (de) 1994-12-08
IT8821663A0 (it) 1988-08-05
EP0353581A3 (en) 1990-08-01
JPH02174675A (ja) 1990-07-06
US5176911A (en) 1993-01-05
ATE113650T1 (de) 1994-11-15

Similar Documents

Publication Publication Date Title
IT1227154B (it) Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
DE69508837T2 (de) Protein enthaltende stabilisierte Formulierung und Dosierungskit
DE68924540D1 (de) Medizinische Aerosolformulierungen.
MX9203278A (es) Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina.
DE69021387T3 (de) Medizinische aerosolformulierungen.
NL300136I1 (nl) Farmacologisch actieve catecholderivaten en samenstellingen ervan.
NO950799D0 (no) Oralt administrerbare farmasöytiske preparater
IT1226549B (it) Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.
DE68903192T2 (de) Orale praeparate.
EP0276543A3 (en) Use of buspirone for the improvement of short term memory
FI914393A0 (fi) Anordning foer soenderdelning av konkrement i kroppen pao en patient.
IT8920405A0 (it) Aminoimidazopiridine farmacologicamente attive.
EP0470431A3 (en) Use of phosphomycin and the pharmaceutically acceptable salts thereof as a topical cicatrizer
IT8546808A1 (it) Dispositivo per l'ammortizzazione delle barelle delle autolettighe in genere.
RU1791101C (ru) Устройство дл обработки шариков
IT8722359A0 (it) Composizioni farmaceutiche per uso orale a base di enzimi ad attivita' proteolitica.
IT8383490A0 (it) Barella per sollevamento di traumatizzati senza necessita' del loro preventivo spostamento.
IT9021846A1 (it) Involucro pretettivo, particolarmente studiato per l'impiego in ambito ospedaliero.
ES1005075Y (es) Mesa de billar articulada.
IT8920404A0 (it) Piperidinilimidazopiridine farmacologicamente attive.
ITTO910276U1 (it) "mutandina in particolare per uso ospedaliero".
ITMI931822A1 (it) Composizioni farmaceutiche a base di nimesulide, somministrabili per via orale, non gastrolesive e/o a rilascio controllato
ES1011838Y (es) Mesa extensible enrollable.
FI890734A0 (fi) Foerfarande vid faestning mellan en raels och en syll foer att installera pao plats anvaenda fjaedrar och en i foerfarandet anvaend faestanordning foer fjaedern.
ES1019568Y (es) Mesa carrito.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970828